Skip to main content

Advertisement

SpringerLink
Log in

Varicella vaccine revisited

  • Letters to the Editor
  • Published:

From Nature Medicine

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Krause, P.R. & Klinman, D.M. Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children. Nature Med. 6, 451–454.

  2. Finger, R., et al. Age-specific incidence of chickenpox. Public Health Rep. 109, 750–755 (1994).

    CAS  PubMed Central  Google Scholar 

  3. Watson, B. et al. Modified chickenpox in children immunized with the OKA/Merck varicella vaccine. Pediatrics 1993; 81:17–22 (1993).

    Google Scholar 

  4. White, C.J. et al. Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response. Ped. Infect. Dis. J. 11, 19–23 (1992).

    Article  CAS  Google Scholar 

  5. Gershon, A. et al. Immunization of healthy adults with live attenuated varicella vaccine. J. Infect. Dis. 158, 132–137 (1998).

    Article  Google Scholar 

  6. Hardy, I. et al. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. N. Engl. J. Med. 325, 1545–1550 (1991).

    Article  CAS  Google Scholar 

  7. Johnson, C. et al. A long-term prospective study of varicella vaccine in healthy children. Pediatrics 100, 761–766 (1997).

    Article  CAS  Google Scholar 

  8. Shapiro, E., Vazquez, M., LaRussa, P., Steinberg, S. & Gershon, A. Protective efficacy of varicella vaccine. in 24th International Herpes Virus Workshop abstract 13.030 (Boston, Massachusetts, 1999).

    Google Scholar 

  9. Sharrar, R. et al. The Postmarketing Safety Profile of Varicella Vaccine. Vaccine In the press.

  10. LaRussa, P., Steinberg, S., Shapiro, E., Vazquez, M. & Gershon, A. Viral Strain Identification in varicella vaccinees with disseminated rashes. Ped. Infect. Dis. In the press.

  11. LaRussa, P. Characterization of a restriction site polymorphism present in DNA from the vaccine strain of varicella zoster virus (VZV). Abstract 453 presented at the 15th International Herpes virus workshop. Washington, D.C.. August 2, 1990.

  12. Arvin, A.M., Pollard, R.B., Rasmussen, L. & Merigan, T. Selective impairment in lymphocyte reactivity to varicella-zoster antigen among untreated lymphoma patients. J. Infect. Dis. 137, 531–540 (1978).

    Article  CAS  Google Scholar 

  13. Brunell, P., Gershon, A.A., Uduman, S.A. & Steinberg, S. Varicella-zoster immunoglobulins during varicella, latency, and zoster. J. Infect. Dis. 132, 49–54 (1975).

    Article  CAS  Google Scholar 

  14. Gershon, A.A., Steinberg, S., Gelb, L. & NIAID-Collaborative-Varicella-Vaccine-Study-Group. Live attenuated varicella vaccine: efficacy for children with leukemia in remission. JAMA 252, 355–362 (1984).

    Article  CAS  Google Scholar 

  15. Williams, V., Gershon, A. & Brunell, P. Serological response to varicella-zoster virus membrane antigens measured by indirect immunofluorescence. J. Infect. Dis. 130, 669 (1974).

    Article  CAS  Google Scholar 

  16. Brunell, P.A. Oka from a generalized rash in a vaccinated child. Pediatrics 106, e28 (2000).

    Article  CAS  Google Scholar 

  17. Weibel, R.E. et al. Live attenuated varicella virus vaccine. Efficacy trial in healthy children. N. Engl. J. Med. 310, 1409–1415 (1984).

    Article  CAS  Google Scholar 

  18. Kuter, B. et al. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine 9, 643–647 (1991).

    Article  CAS  Google Scholar 

  19. Moffat, J.F. et al. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in α-herpesvirus virulence demonstrated in the SCID-hu mouse. J. Virol. 72, 965–974 (1998).

    CAS  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Varicella Activity National Immunizationn Program National VCV Laboratory, National Center for Infectous Diseases Centers for Disease Control and Prevention, 1600 Clifton Rd. MS E-61, Atlanta, 30333, GA

    Jane Seward, Aisha Jumaan & Scott Schmid

  2. National VCV Laboratory,

    Jane Seward, Aisha Jumaan & Scott Schmid

Authors
  1. Jane Seward
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aisha Jumaan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Scott Schmid
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seward, J., Jumaan, A. & Schmid, S. Varicella vaccine revisited. Nat Med 6, 1298–1299 (2000). https://doi.org/10.1038/82068

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/82068

  • Springer Nature America, Inc.

Search

Navigation